CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

~~EXCHANGE~~Date ~~ACT~~of OFReport ~~1934~~(Date of earliest event reported): February 1, 2007

~~Date~~IOMED, ~~of Report~~ Inc. (~~Date~~Exact name of ~~earliest~~ ~~event~~registrant ~~reported):~~as ~~May~~specified ~~26,~~in ~~2006~~its charter)

IOMED, Inc.

Utah	1-14059	87-0441272
(State or other jurisdiction of	(Commission	(I.R.S. Employer
Incorporation or organization)	File Number)	Identification No.)

(Exact name of registrant as specified in its charter)

2441 South 3850 West, Salt Lake City, Utah		84120
(Address of principal executive offices)		(Zip Code)

Utah	1-14059	87-0441272
(State or other jurisdiction of	(Commission	(I.R.S. Employer
Incorporation or organization)	File Number)	Identification No.)
2441 South 3850 West, Salt Lake City, Utah		84120
(Address of principal executive offices)		(Zip Code)

(801) 975-1191
(Registrant’s telephone number, including area code)

N/A (801Former name or former address, if changed since last report) 975-1191

~~(Registrant’s~~Check the appropriate box ~~telephone~~below ~~number,~~if ~~including~~the ~~area~~Form ~~code)~~8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

~~N/A~~o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

~~(Former~~o Soliciting ~~name~~material orpursuant to Rule 14a-12 ~~former~~under ~~address,~~the ifExchange ~~changed~~Act ~~since~~(17 ~~last~~CFR ~~report~~240.14a-12)

~~Check the appropriate box below if the Form 8~~o Pre-Kcommencement ~~filing~~communications ispursuant ~~intended~~ to ~~simultaneously satisfy the filing~~ ~~obligation~~Rule of14d-2(b) ~~the registrant~~ under ~~any~~the ofExchange ~~the~~Act ~~following~~(17 ~~provisions:~~CFR 240.14d-2(b))

o ~~Written~~ Pre-commencement ~~communications~~communication pursuant to Rule ~~425~~13e-4(c) under the ~~Securities~~Exchange Act (17 CFR ~~230~~240.~~425~~13e-4(c))

~~o Soliciting~~Item ~~material~~2.02 ~~pursuant~~Results toof ~~Rule~~Operations ~~14a-12~~and ~~under~~Financial ~~the Exchange Act (17 CFR 240.14a-12)~~Condition

o The ~~Pre-commencement~~information ~~communications~~contained ~~pursuant~~in tothis ~~Rule~~Item ~~14d-~~2~~(b)~~.02 and the exhibit hereto are being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, and shall not be deemed incorporated by reference in any filing with the Securities and Exchange Commission under the Securities Exchange Act ~~(17~~of ~~CFR~~1934 ~~240~~or the Securities Act of 1933, whether made before or after the date hereof and irrespective of any general incorporation language in any filings.~~14d-2(b))~~

o On ~~Pre-commencement~~February ~~communication~~1, ~~pursuant~~2007, tothe ~~Rule~~Company ~~13e-4(c)~~issued ~~under~~a ~~the~~press release announcing financial ~~Exchange~~results ~~Act~~for ~~(17~~the ~~CFR~~fiscal ~~240~~2007 second quarter ended December 31, 2006.~~13e~~ The press release is attached as Exhibit 99.1 to this Current Report on Form 8-~~4(c))~~K.

Item 59.0201 ElectionFinancial ofStatements Directorand Exhibits

Effective May 26, 2006, IOMED, Inc.’s Board of Directors appointed D. Stephen Antion to the Board, increasing the Board to six members. Mr. Antion will serve as a Class II director of the Company until the 2008 annual meeting of shareholders. There is no agreement or understanding between Mr. Antion and any other person pursuant to which he was appointed to the Board. Mr. Antion is not a party to any transactions with the Company that would require disclosure under Item 404(ad) ~~of Regulation S-K~~Exhibits.

~~Mr.~~The ~~Antion,~~following ~~44,~~exhibits ~~is currently~~are ~~President~~furnished ofwith ~~Ridgestone~~this ~~Corporation, a private equity firm that is~~Current ~~engaged~~Report inon ~~the~~Form ~~business of investing in middle market companies, which owns 19.~~8~~% of the Company’s outstanding common shares. Ridgestone is the Company’s largest shareholder.~~-K:

A copy of the press release announcing Mr. Antion’s appointment is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K and is incorporate herein by reference.

Exhibit Number		Description
99.1*		Press Release Dated February 1, 2007.

~~Item~~* ~~9.01~~This ~~Financial~~information shall ~~Statements~~not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, and ~~Exhibits~~shall not be deemed incorporated by reference in any filing with the Securities and Exchange Commission under the Securities Exchange Act of 1934 or the Securities Act of 1933, whether made before or after the date hereof and irrespective of any general incorporation language in any filings.

~~(d) Exhibits.~~Signature

~~The following~~Pursuant ~~exhibits~~to ~~are~~the ~~furnished~~requirements ~~with~~of the Securities Exchange Act of 1934, the registrant has duly caused this ~~Current~~report ~~Report~~to be signed on ~~Form~~its ~~8-K:~~behalf by the undersigned hereunto duly authorized.

Exhibit Number		Description
DATED: February 1, 2007	Iomed, Inc.
99.1*		Press Release Dated May 26, 2006.
	By:	/s/ Robert J. Lollini
		Robert J. Lollini
		President and Chief Executive Officer

~~Signature~~2

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

DATED: May 30, 2006	Iomed, Inc.
	By:	/s/ Robert J. Lollini
		Robert J. Lollini
		President and Chief Executive Officer

Filing Compare · IOMED LLC